Samsara Vision

07/23/2025

🔦EMPLOYEE SPOTLIGHT: Riley Francis is Samsara Vision’s summer intern, and she is currently fulfilling the role of Chief of Staff.

The Chief of Staff role allows her to contribute across various departments and tackle special projects assigned to her by Samsara Vision’s CEO, Tom Ruggia.

Riley is going into her final year at the University of Michigan, pursuing a degree in Neuroscience and minoring in Biochemistry. She comes to Samsara with practical experience working alongside surgeons, aligning with her goal of attending medical school.

Riley was also a Division 1 Varsity athlete on the Women's Swim team at the University of Michigan. She competed at elite levels, including semi-finaling at the U.S. Olympic Trials, as well as honored Second-Team All-Big Ten Conference.

Go Blue! And go Riley!

07/11/2025

Who is Samsara Vision helping? How we doing it? And why is our work important now more than ever?

Samsara Vision’s CEO and President, Tom Ruggia, answers these questions and more in his latest interview. Thank you to LSI - Life Science Intelligence for having Tom in the studio last month and allowing him to share our story.

Catch Tom’s full interview here: https://www.youtube.com/watch?v=Ho5z9W8lCTY&list=PLGHWsPGjDe4PBzPFK9ZVM1KywDa8T8h0P

Please note: the device is currently available in CE-marked countries. Samsara Vision is working with the FDA to bring this technology to U.S. health care providers.

Tom Ruggia joined us in the LSI Studio at LSI USA ‘25 in Dana Point, California.Samsara Vision, Inc. is a privately held specialty medical device company eng...

07/10/2025

👁️People living with late-stage age-related macular degeneration (AMD) feel very limited in their everyday lives. They can no longer see what’s straight ahead, making simple tasks difficult.

Samsara Vision is reimagining life for people living with late-stage AMD. We make miniaturized telescopes that can be placed safely in the eye by an ophthalmic surgeon.

🔭Based on the principles of Galileo, our implantable telescopes help the peripheral parts of the retina ‘see’ the image viewed in straight-ahead vision.

Our research will continue to push the technology envelope and improve quality of life for people living with severe vision disorders. Learn more about our novel telescope design: https://www.samsaravision.com/implantable-telescope-technology

07/08/2025

AMD is the leading cause of vision loss and blindness for Americans aged 65 years and older, yet stigma still exists. In this clip, Dr. David Eichenbaum tells Samsara Vision’s Rebecca Kammer how this stigma manifests in his practice.

07/03/2025

“[The study] underscores the SING IMT’s efficacy, safety and the critical role of structured rehabilitation programs in maximizing patient outcomes and offering an effective solution where alternative treatments
fail to fully restore vision.”

Mario Damiano Toro, PhD, DiSSO, FEBO shared his insights on Samsara Vision’s 6-month study of the SING IMT®️ in patients with late-stage AMD.

Read more in the article here: https://www.healio.com/news/ophthalmology/20250213/sing-imt-improves-distance-near-vision-at-6-months-in-patients-with-latestage-amd

The device is currently available in CE-marked countries. Visit the SING IMT ‘On-Demand’ Portal with the password: SINGIMT to learn more about bringing this life-altering device to your late-stage AMD patients: www.singimt.com

Please note: the device is not currently approved in the U.S. Samsara Vision is working with the FDA to bring this technology to U.S. health care providers.

07/01/2025

An AMD diagnosis can be overwhelming for patients, but sometimes, just knowing the right questions to ask can be a stress reliever. The National Eye Institute’s guide can help patients navigate their first appointments post-diagnosis. Share this with your patients to make the process a little less stressful: https://www.nei.nih.gov/learn-about-eye-health/outreach-resources/outreach-materials/talk-your-doctor-about-amd

06/24/2025

This month’s Employee Feature is Tom Scott, Senior Director of Clinical and Business Development. Tom joined the team in March, and with his passion for helping patients improve their vision, he has an been a valuable addition to the team.

Tom’s impressive background in the ophthalmology and retina field includes the following highlights:

👁️ Time at Allergan where he gained a strong foundation in ophthalmology.
👁️ A transition to the retina space as the Florida Team Leader for Visudyne.
👁️ 13.5 years at Genentech, where he focused on promoting the anti-VEGF therapy, Lucentis.
👁️ A role as Thought Leader Liaison at Alimera Sciences, supporting both Yutiq and Iluvien

When Tom’s not working, he enjoys anything water related. He can often be found on a cruise ship, at the beach, riding his Seadoo, or reeling in a monster fish.

Thanks for being a part of the Samsara Vision family, Tom.

06/19/2025

Samsara Vision’s busy week on the road continues. Rebecca Kammer and Tom Scott head to Newport Beach, California for Ophthalmology Tech Forum.

This is an exciting event for industry leaders and top ophthalmologists to discuss the future of the industry, from cutting-edge breakthroughs to advancements in technology.

Becky and Tom will be taking meetings with physicians and industry partners. Send us to DM to get on their schedule and learn about our clinical trial investigating the SING IMT®️, a groundbreaking intraocular telescope for late-stage AMD patients.

The SING IMT®️ is currently approved in CE-marked countries and under FDA investigation in the U.S.

06/17/2025

Next week, Samsara Vision’s Rebecca Kammer will head to Minneapolis for Optometry's Meeting® | 5th World Congress of Optometry. This event promises discussion topics such as advancing universal access to high-quality vision care and technological advancements across the eye health care industry. This is a fantastic opportunity for Becky to meet fellow KOLs and raise visibility around Samsara’s innovative intraocular telescope.

Send us a DM if you’ll be there, too.

American Optometric Association

06/16/2025

🆕New article in the International Journal of Telerehabilitation co-authored by Samsara's Becky Kammer.

Rehabilitation can benefit people with low vision, helping them carry out daily activities and learn new skills. This type of support can improve their quality of life, even with vision loss.

However, many do not have easy access to these rehabilitation services.

During the COVID-19 pandemic, telehealth became more common, allowing for new ways to provide healthcare, including telerehabilitation for low vision.

Becky, Reilly Federici, and Stasi Gormley evaluated the current evidence regarding telerehabilitation conducted by occupational therapists for patients with low vision.

The results of a multicenter, randomized controlled trial found that reading ability significantly improved. Results did not differ between therapies conducted through telerehabilitation or in-office.

Furthermore, patient and provider comfort level and overall satisfaction were similar between in-office visits and telerehabilitation.

https://telerehab.hpu.edu/index.php/Telerehab/article/view/6703

06/12/2025

Clinical Trials at the Summit (CTS) 2025 is fast approaching and the Samsara team is looking forward to hearing about the latest clinical trials and data in vitreoretinal care.

Rebecca Kammer and Tom Scott from the Samsara team are currently setting up meetings with physicians and industry partners. If you’re going, be sure to send us a DM to connect with them.

06/10/2025

Our purpose is to help patients with late-stage macular degeneration. Contact us to learn more about our innovative intraocular telescope, currently approved in CE-marked countries and under FDA investigation in the U.S. https://www.samsaravision.com/contact